ORAMED PHARMACEUTICALS INC. Basic Shares Outstanding (Weighted Average)
ORAMED PHARMACEUTICALS INC. (ORMP) reported Basic Shares Outstanding (Weighted Average) of 41.04 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- ORAMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 41.04M shares, a 1.68% decline year-over-year.
- ORAMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 40.77M shares, a 1.10% decline year-over-year.
- ORAMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 40.90M shares, a 0.36% increase year-over-year.
- ORAMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 41.76M shares, a 2.10% increase year-over-year.
- ORAMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2025 was 41.40M shares, a 1.35% increase from fiscal 2024.
- ORAMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2024 was 40.85M shares, a 1.33% increase from fiscal 2023.
- ORAMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2023 was 40.32M shares, a 3.38% increase from fiscal 2022.
- ORAMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2022 was 39.00M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 4 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 8 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 41.04M shares 10-Q · filed 2026-08-10 | 40.91M shares 10-Q · filed 2026-08-10 | 40.91M shares derived: average of 3 quarters · filed 2026-08-10 | 41.12M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | 40.77M shares 10-Q · filed 2026-05-19 | 40.84M shares derived: average of 2 quarters · filed 2026-05-19 | 41.14M shares derived: average of 3 quarters · filed 2026-05-19 | 41.29M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | 40.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 41.33M shares derived: average of 2 quarters · filed 2026-03-26 | 41.47M shares derived: average of 3 quarters · filed 2026-08-10 | 41.40M shares 10-K · filed 2026-03-26 | |||
| 2025-09-30 | 41.76M shares 10-Q · filed 2025-11-13 | 41.75M shares derived: average of 2 quarters · filed 2026-08-10 | 41.57M shares 10-Q · filed 2025-11-13 | 41.37M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2025-06-30 | 41.74M shares 10-Q · filed 2026-08-10 | 41.49M shares 10-Q · filed 2026-08-10 | 41.24M shares derived: average of 3 quarters · filed 2026-08-10 | 41.16M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | 41.23M shares 10-Q · filed 2026-05-19 | 40.99M shares derived: average of 2 quarters · filed 2026-05-19 | 40.96M shares derived: average of 3 quarters · filed 2026-05-19 | 40.96M shares derived: average of 4 quarters · filed 2026-05-19 | |||
| 2024-12-31 | 40.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 40.83M shares derived: average of 2 quarters · filed 2026-03-26 | 40.87M shares derived: average of 3 quarters · filed 2026-03-26 | 40.85M shares 10-K · filed 2026-03-26 | 40.83M shares 10-K · filed 2025-03-27 | ||
| 2024-09-30 | 40.90M shares 10-Q · filed 2025-11-13 | 40.93M shares derived: average of 2 quarters · filed 2025-11-13 | 40.88M shares 10-Q · filed 2025-11-13 | 40.80M shares derived: average of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | 40.96M shares 10-Q · filed 2025-08-14 | 40.90M shares 10-Q · filed 2025-08-14 | 40.77M shares derived: average of 3 quarters · filed 2025-08-14 | 40.69M shares derived: average of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | 40.84M shares 10-Q · filed 2025-05-15 | 40.68M shares derived: average of 2 quarters · filed 2025-05-15 | 40.60M shares derived: average of 3 quarters · filed 2025-05-15 | 40.51M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | 40.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 40.48M shares derived: average of 2 quarters · filed 2025-03-27 | 40.40M shares derived: average of 3 quarters · filed 2025-03-27 | 40.32M shares 10-K · filed 2025-03-27 | |||
| 2023-09-30 | 40.45M shares 10-Q · filed 2024-11-07 | 40.34M shares derived: average of 2 quarters · filed 2024-11-07 | 40.25M shares 10-Q · filed 2024-11-07 | 40.03M shares derived: average of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | 40.23M shares 10-Q · filed 2024-08-14 | 40.14M shares 10-Q · filed 2024-08-14 | 39.90M shares derived: average of 3 quarters · filed 2024-08-14 | 39.70M shares derived: average of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | 40.04M shares 10-Q · filed 2024-05-09 | 39.73M shares derived: average of 2 quarters · filed 2024-05-09 | 39.52M shares derived: average of 3 quarters · filed 2024-05-09 | 39.34M shares derived: average of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | 39.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | 37.11M shares 10-K · filed 2023-03-06 | 39.26M shares derived: average of 2 quarters · filed 2024-03-06 | 39.11M shares derived: average of 3 quarters · filed 2024-03-06 | 39.00M shares 10-K · filed 2024-03-06 | ||
| 2022-09-30 | 39.10M shares 10-Q · filed 2023-11-09 | 38.95M shares derived: average of 2 quarters · filed 2023-11-09 | 38.86M shares 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | 38.80M shares 10-Q · filed 2023-08-10 | 38.73M shares 10-Q · filed 2023-08-10 | |||||
| 2022-03-31 | 38.68M shares 10-Q · filed 2023-05-11 | ||||||
| 2021-09-30 | 34.54M shares 10-Q · filed 2022-11-10 | 32.63M shares derived: average of 2 quarters · filed 2022-11-10 | 31.10M shares 10-Q · filed 2022-11-10 | ||||
| 2021-08-31 | 28.47M shares 10-K · filed 2023-03-06 | ||||||
| 2021-06-30 | 30.72M shares 10-Q · filed 2022-08-10 | 29.35M shares 10-Q · filed 2022-08-10 | |||||
| 2021-03-31 | 27.96M shares 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |